RE:35% CRR on PapillaryI seem to remember that somone brought this up before and it turned out that the statistical certainty of the 35% number wasn't high enough to go to the FDA with without additional data. Because of this, they have tried not to highlight it so that they appear to give a consistent message to both the FDA and to investors. Can't remember who said this but I think it was on this board.